Dr Reddy Q2 Results 2025. The bottom line of the pharmaceutical company declined 9% year. ₹80.2b (up 17% from 2q 2024).
Reddy’s laboratories announced q2fy24 results: It is my pleasure to interact with you for the first time and present results for q2 fy 2025.
